Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$614,108
+$139,507 QoQ
Shares Held
512
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#3,576
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Madison Park Capital Advisors, LLC holds $1,308,978 across 2 Drug Manufacturers - General names. LLY ranks #2 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
5,500 | $694,870 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
512 | $614,108 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $614,108 | 512 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $474,601 | 516 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $550,236 | 512 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $387,604 | 508 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $325,843 | 418 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $338,623 | 410 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $314,204 | 407 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $498,784 | 563 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $507,012 | 560 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $418,542 | 538 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $325,269 | 558 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||